- Home
- CPS vs CLLS Comparison
CPS vs CLLS Comparison
Compare CPS & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPS
- CLLS
- Stock Information
- Founded
- CPS 1960
- CLLS 1999
- Country
- CPS United States
- CLLS France
- Employees
- CPS N/A
- CLLS N/A
- Industry
- CPS Auto Parts:O.E.M.
- CLLS Biotechnology: Pharmaceutical Preparations
- Sector
- CPS Consumer Discretionary
- CLLS Health Care
- Exchange
- CPS Nasdaq
- CLLS Nasdaq
- Market Cap
- CPS 280.3M
- CLLS 240.2M
- IPO Year
- CPS N/A
- CLLS 2007
- Fundamental
- Price
- CPS $14.70
- CLLS $1.87
- Analyst Decision
- CPS
- CLLS Buy
- Analyst Count
- CPS 0
- CLLS 3
- Target Price
- CPS N/A
- CLLS $7.00
- AVG Volume (30 Days)
- CPS 178.8K
- CLLS 93.0K
- Earning Date
- CPS 10-31-2024
- CLLS 11-04-2024
- Dividend Yield
- CPS N/A
- CLLS N/A
- EPS Growth
- CPS N/A
- CLLS N/A
- EPS
- CPS N/A
- CLLS N/A
- Revenue
- CPS $2,743,783,000.00
- CLLS $36,042,000.00
- Revenue This Year
- CPS N/A
- CLLS $271.02
- Revenue Next Year
- CPS $9.07
- CLLS $33.48
- P/E Ratio
- CPS N/A
- CLLS N/A
- Revenue Growth
- CPS N/A
- CLLS 46.96
- 52 Week Low
- CPS $11.24
- CLLS $1.70
- 52 Week High
- CPS $20.82
- CLLS $3.77
- Technical
- Relative Strength Index (RSI)
- CPS 49.25
- CLLS 47.58
- Support Level
- CPS $15.70
- CLLS $1.70
- Resistance Level
- CPS $17.37
- CLLS $2.00
- Average True Range (ATR)
- CPS 1.00
- CLLS 0.11
- MACD
- CPS 0.07
- CLLS 0.02
- Stochastic Oscillator
- CPS 44.61
- CLLS 56.67
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is a supplier of rubber and resin products for the automotive industry. The company produces rubber and plastic sealings, fuel and brake lines, fluid transfer hoses, and anti-vibration systems used by original equipment manufacturers and replacement markets for passenger vehicles and light trucks. The largest customers include Ford, GM, FCA, Peugeot Citroen, and Volkswagen. Cooper Standard generates the majority of its revenue with its sealing systems products such as Fortrex, dynamic and static seals, stainless steel trims, flush glass systems, and variable extrusions.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.